Intriguing new data from a recent study indicates that the active forms of vitamin D can inhibit the replication and expansion of COVID-19. The study also suggests that lumisterol, produced by a chemical reaction in the body using light, works to block COVID-19.
Vitamin D and lumisterol metabolites were able to block two specific enzymes (RdRP and Mrpo) required for the SARS-CoV-2 life cycle, according to the team of researchers from the University of Alabama at Birmingham, the Centre for Interdisciplinary Research in Basic Sciences in New Delhi, India, and the University of Western Australia.
Once vitamin D is consumed, it is metabolized into various active forms by enzymes called cytochrome oxidases or CYP enzymes. Researchers on this study say their findings help explain a possible mechanism for why low vitamin D levels seem to promote COVID-19 infection and poor outcome in certain individuals. This correlates to other studies showing a relationship between vitamin D deficiency and poor disease outcomes. More studies and clinical trials are planned to test the efficacy of vitamin D and lumisterol as an antiviral therapeutic for COVID-19 in animals and humans.
I will also add this if the Pharmaceutical Industry has their money on any of the “more studies and clinical trials”, I can guarantee you that they will purposely use inadequate amounts of vitamin D in their research to sabotage the results, or at the very least suppress the results. Research Dr. Holick and vitamin D, I highly recommend you watch this Dr. Holick presentation on vitamin D on Youtube and educate yourself from websites such as Vitamindwiki.com.
Read the full article, “Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes.”